Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro

Amyloid

Volumn 4, Issue 4, 1997, Pages 223-232

  Naiki, Hironobu ^a   Hashimoto, Norikazu ^a   Suzuki, Satoru ^a   Kimura, Hideki ^a   Nakakuki, Kazuya ^a   Gejyo, Fumitake ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Dialysis related amyloidosis; First order kinetic model; Fluorometry; Nucleation dependent polymerization model; Thioflavine T; 2 microglobulin

Indexed keywords

EID: 0000079910     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129709003833     Document Type: Article

References (36)

1. Warren DJ and Otieno LS (1975). Carpal tunnel syndrome in patients on intermittent haemodialysis. Postgrad Med J 51, 450-452
2. Gejyo F and Arakawa M (1990). Dialysis amyloidosis: Current disease concepts and new perspectives for its treatment. Contrib Nephrol 78, 47-60
3. Gejyo F, Homma N and Arakawa M (1989). Carpal tunnel syndrome and beta-2 microglobulin amyloidosis: Histological and biochemical aspects. In Gejyo F, Brancaccio D and Bardin T (ed.) Dialysis Amyloidosis, pp. 35-56. (Milano: Wichtig Editore)
4. 2-microglobulin. Biochem Biophys Res Commun 129, 701-706
5. Chanard J, Bindi P, Lavaud S, Toupance O, Maheut H and Lacour F (1989). Carpal tunnel syndrome and type of dialysis membrane. Br Med J 298, 867-868
6. van Ypersele de Strihou, Jadoul M, Malghem J, Maldague B, Jamart J and the Working Party on Dialysis Amyloidosis (1991). Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 39, 1012-1019
7. Davison AM (1995). β2-Microglobulin and amyloidosis: Who is at risk? Nephrol Dial Transplant 10 (Suppl 10), 48-51
8. Yamada T, Kakihara T, Gejyo F and Okada M (1994). A monoclonal antibody recognizing apolipoprotein E peptides in systemic amyloid deposits. Ann Clin Lab Sci 24, 243-249
9. Gejyo F, Suzuki S, Kimura H, Imura T, Ei I, Hasegawa H and Arakawa M (1997). Increased risk of dialysis-related amyloidosis in patients with the apolipoprotein E4 allele. Amyloid: Int J Exp Clin Invest 4, 13-17
10. Castaño EM, Prelli FC and Frangione B (1995). Apolipoprotein E and amyloidogenesis. Lab Invest 73, 457-460
11. 2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92, 1243-1252
12. 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1. J Clin Invest 93, 521-528
13. Takeda T, Hosokawa M and Higuchi K (1991). Senescence-accelerated mouse (SAM): A novel murine model of accelerated senescence. J Am Geriatr Soc 39, 911-919
14. Naiki H, Higuchi K, Hosokawa M and Takeda T (1989). Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T. Anal Biochem 177, 244-249
15. Naiki H, Higuchi K, Matsushima K, Shimada A, Chen W-H, Hosokawa M and Takeda T (1990). Fluorometric examination of tissue amyloid fibrils in murine senile amyloidosis: Use of the fluorescent indicator, thioflavine T. Lab Invest 62, 768-773
16. Naiki H, Higuchi K, Nakakuki K and Takeda T (1991). Kinetic analysis of amyloid fibril polymerization in vitro. Lab Invest 65, 104-110
17. Maury CPJ, Nurmiaho-Lassila EL and Rossi H (1994). Amyloid fibril formation in gelsolin-derived amyloidosis: Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides. Lab Invest 70, 558-564
18. LeVine H, III (1993). ThioflavineT interaction with synthetic Alzheimer's disease β- amyloid peptides: Detection of amyloid aggregation in solution. Prot Sci 2, 404-410
19. Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K and Cerami A (1994). Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91, 4766-4770
20. Wisniewski T, Castaño EM, Golabek A, Vogel T and Frangione B (1994). Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 145, 1030-1035
21. Golabek AA, Soto C, Vogel T and Wisniewski T (1996). The interaction between apolipoprotein E and Alzheimer's amyloid β- peptide is dependent on β- peptide conformation. J Biol Chem 271, 10602-10606
22. Brancaccio D, Ghiggeri G, Garberi A, Anelli A, Ginevri F, Loggi G and Gusmano R (1991). Purification and partial characterization of a new 85 kDa amyloidosis-related protein in chronic hemodialysis. Biochem Biophys Res Commun 176, 1037-1043
23. Naiki H and Nakakuki K (1996). First-order kinetic model of Alzheimer's β- amyloid fibril extension in vitro. Lab Invest 74, 374-383
24. Jarrett JT and Lansbury PT Jr (1993). Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058
25. Esler WP, Stimson ER, Ghilardi JR, Vinters HV, Lee JP, Mantyh PW and Maggio JE (1996). In vitro growth of Alzheimer's disease β- amyloid plaques displays first-order kinetics. Biochemistry 35, 749-757
26. Soreghan B, Kosmoski J and Glabe C (1994). Surfactant properties of Alzheimer's Aβ peptides and the mechanism of amyloid aggregation. J Biol Chem 269, 28551-28554
27. 2-microglobulin scintigraphy in patients with dialysis amyloidosis. Clin Nephrol 44, 14-18
28. Pras M, Zucker-Franklin D, Rimon A and Franklin EC (1969). Physical, chemical, and ultrastructural studies of water-soluble human amyloid fibrils. J Exp Med 130, 777-791
29. Schägger H and von Jagow G (1987). Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166, 368-379
30. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254
31. Hall PW, Ricanati E and Vacca CV (1977). Characterization of human beta2-microglobulin by isoelectric focusing. Clin Chim Acta 77, 37-42
32. Glenner GG, Ein D, Eanes ED, Bladen HA, Terry W and Page DL (1971). Creation of "amyloid" fibrils from Bence Jones proteins in vitro. Science 174, 712-714
33. Shirahama T and Cohen AS (1975). Intralysosomal formation of amyloid fibrils. Am J Pathol 81, 101-116
34. Lai Z, Colón W and Kelly JW (1996). The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35, 6470-6482
35. Evans KC, Berger EP, Cho C-G, Weisgraber KH and Lansbury PT Jr (1995). Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci USA 92, 763-767
36. Naiki H, Gejyo F and Nakakuki K (1997). Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's β- amyloid fibril formation in vitro. Biochemistry 36, 6243-6250